CTRI/2013/10/004061已完成4 期
Tacrolimus combined with corticosteroids versus modified ponticelli regimen in treatment of idiopathic membranous nephropathy: randomized control trial
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- PGIMER
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Biopsy proven idiopathic membranous nephropathy
- •2.Nephrotic syndrome with proteinuria ( >4 gm/day) or >=2.0 gm/day along with serum albumin <2.5gm/dl
- •3.At least 6 months on ACEi or ARBs treatment or anyone with severe complicated nephrotic syndrome
- •4.Age 18-60 yrs with informed consent
排除标准
- •1.Serum creatinine >2.5mg/dl
- •2.Patients with abnormal liver function tests and diabetes mellitus
- •3.Active infection
- •4.Patient with prior therapy with steroids, cyclophosphamide, sirolimus, CSA, MMF, azathioprine and rituximab.
- •5.Patients with secondary cause
研究者
相似试验
已完成
不适用
Tacrolimus monotherapy for uveitisveitisEye DiseasesDisorders of globeISRCTN46576063nited Bristol Healthcare Trust (UK)40
已完成
3 期
Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.Liver TransplantationNCT00295594Astellas Pharma Inc627
已完成
4 期
A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic SyndromeMinimal Change Nephrotic Syndrome (MCNS)MCNSNCT01763580Astellas Pharma Korea, Inc.144
招募中
不适用
Management of the combination of tacrolimus with azoles: effect of tacrolimus formulation on drug-drug interaction magnitudeMycoses due to opportunistic pathogensfungal infection in patients with immune deficiencies who would otherwise not be infected10017528NL-OMON54925niversitair Medisch Centrum Groningen24
已完成
不适用
Combination therapy of tacrolimus and intravenous cyclophosphamide for remission induction of lupus nephritislupus nephritisJPRN-UMIN000004893Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University16